Do not take ADCO-DOL:
- If you are hypersensitive (allergic) to any of the above listed ingredients of ADCO-DOL.
- If you have respiratory depression (unusual breathing), especially in the presence of cyanosis (blueish discolourisation of skin) and excessive bronchial secretion.
- After operations on the biliary tract, acute alcoholism, head injuries and conditions in which intracranial (inside skull) pressure is raised.
- It should not be given during an attack of bronchial asthma or in heart failure secondary to chronic lung disease.
Warnings and precautions
Special care should be taken with ADCO-DOL
- This product contains paracetamol which may be fatal in overdose. In the event of overdosage or suspected overdose and notwithstanding the fact that the person may be asymptomatic, the nearest doctor, hospital or Poison Centre must be contacted immediately.
- This medicine may lead to drowsiness and impaired concentration, which is aggravated by the simultaneous intake of alcohol or other central nervous system depressant agents.
- Paracetamol dosages in excess of those recommended may cause severe liver damage.
- Exceeding the prescribed dose, together with prolonged and continuous use of this medication, may lead to dependency and addiction.
- In patients with low thyroid function, Addison’s disease (low levels of cortisol and aldosterone), liver damage, enlarged prostate or shock.
- It should be used with caution in patients with inflammatory or obstructive bowel disorders.
- The dosage should be reduced in elderly and debilitated patients.
- It should be used with care in patients with glaucoma and enlarged prostate.
Use in children and adolescents
Adults and children over 12 years: One or two tablets repeated four hourly if necessary. Do not exceed eight tablets per day.
Other medicines and ADCO-DOL
Always tell your healthcare professional if you are taking any other medicine. Monoamine oxidase inhibitors or within 14 days of stopping such treatment. The effects of atropine and tricyclic antidepressants may be enhanced. The warning symptoms of damage caused by ototoxic drugs may be masked and the metabolism of drugs in the liver may be affected. Doxylamine may decrease emetic response to apomorphine. Doxylamine succinate may enhance the sedative effect of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives and tranquillisers. The depressant effects of codeine are enhanced by depressants of the central nervous system such as alcohol, anaesthetics, hypnotics and sedatives, and phenothiazines.
ADCO-DOL with food and drinks
No known interactions with food and drink.
Pregnancy, breastfeeding and fertility
Safety in pregnancy and lactation has not been established. If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other healthcare professional for advice before taking this medicine.
Driving and using machines
Patients should be warned against driving vehicles or machinery or performing potentially hazardous tasks where loss of concentration may lead to accidents. It is not always possible to predict to what extent ADCO-DOL may interfere with the daily activities of a patient. Patients should ensure that they do not engage in the above activities until they are aware of the measure to which ADCO-DOL affects them.